Files

T

Fabio 5941153bb7 Legislation: batch B — IL IN KS KY LA MA MD ME MI MN

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

2026-07-06 17:27:20 -04:00

5.0 KiB

Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type

title

description

jurisdiction

legislature

session

identifier

citation

classification

subjects

status

primary_sponsors

version_count

action_count

vote_count

first_action

last_action

source

source_identifier

source_url

source_hash

vintage

source_snapshot

retrieved_at

confidence

Louisiana HB 316 (2021) — CHILDREN/NEWBORNS: Adds mucopolysaccharidosis type I and glycogen storage disorder type II to the state's newborn screening panel (EN +$187,717 GF EX See Note)

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

HB316 Original (filed) — source
HB316 Act (committee substitute) — source
HB316 Engrossed (committee substitute) — source
HB316 Reengrossed (committee substitute) — source
House Floor Amendment, #2739, Emerson, Adopted (committee substitute) — source
Senate Committee Amendment, #2952, FNCE, Draft (committee substitute) — source
Senate Committee Amendment, #3013, FNCE, Adopted (committee substitute) — source
HB316 Enrolled (enrolled) — source

Votes

FINAL PASSAGE (#497) — 99–0 (pass) · lower
CONCUR IN SENATE AMENDMENTS (#1017) — 98–0 (pass) · lower
FINAL PASSAGE (#724) — 36–0 (pass) · upper

Timeline

The legislative action history — every referral, reading, and vote.

2021-06-14 Effective date: 01/01/2022.
2021-06-14 Signed by the Governor. Becomes Act No. 305. executive-signature
2021-06-11 Sent to the Governor for executive approval. executive-receipt
2021-06-09 Signed by the President of the Senate.
2021-06-08 Enrolled and signed by the Speaker of the House.
2021-06-07 Read by title, roll called, yeas 98, nays 0, Senate amendments concurred in.
2021-06-03 Scheduled for concurrence on 06/07/2021.
2021-06-03 Received from the Senate with amendments.
2021-06-02 The amended bill was read by title, passed by a vote of 36 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. passage
2021-06-01 Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
2021-06-01 Reported with amendments. Rules suspended. Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
2021-05-27 Read by title. Recommitted to the Committee on Finance.
2021-05-26 Reported favorably.
2021-05-20 Read second time by title and referred to the Committee on Health and Welfare. referral-committee
2021-05-19 Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
2021-05-18 Read third time by title, amended, roll called on final passage, yeas 99, nays 0. Finally passed, title adopted, ordered to the Senate. passage
2021-05-13 Scheduled for floor debate on 05/18/2021.
2021-05-12 Read by title, passed to 3rd reading.
2021-05-11 Reported favorably (19-0).
2021-04-27 Read by title, ordered engrossed, recommitted to the Committee on Appropriations.
2021-04-26 Reported favorably (15-0).
2021-04-12 Read by title, under the rules, referred to the Committee on Health and Welfare. referral-committee
2021-04-02 First appeared in the Interim Calendar on 4/2/2021.
2021-03-30 Under the rules, provisionally referred to the Committee on Health and Welfare. referral-committee
2021-03-30 Prefiled. filing

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/2deff1fd-c5df-4c5d-aba9-2d99c9573a2f. Confidence: reported (aggregated from official Louisiana legislature records).

5.0 KiB Raw Permalink Blame History Unescape Escape